Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kyverna Therapeutics

3.47
+0.400013.03%
Volume:852.40K
Turnover:2.87M
Market Cap:149.97M
PE:-1.03
High:3.61
Open:3.15
Low:3.10
Close:3.07
Loading ...
Jul 15, 2024

Major Issues Report

Form 8-K - Current report
Jun 14, 2024

Major Issues Report

Form 8-K - Current report
May 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2024

Major Issues Report

Form 8-K - Current report
May 03, 2024

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Mar 26, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 26, 2024

Major Issues Report

Form 8-K - Current report
Feb 22, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 20, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2024

Major Issues Report

Form 8-K - Current report
Feb 08, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 06, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Feb 06, 2024

Correspondence

Form CORRESP - Correspondence
Feb 06, 2024

Correspondence

Form CORRESP - Correspondence
Feb 01, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jan 26, 2024

Correspondence

Form CORRESP - Correspondence
Jan 17, 2024

Correspondence

Form CORRESP - Correspondence
Jan 16, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933